Equinor Says Production at North Sea Breidablikk Field Has Started
By Dominic Chopping
Equinor said production at the Breidablikk field in the North Sea started Friday, four months ahead of schedule and within budget.
The Norwegian energy major said that when the plan for development and operation was submitted in September 2020, production from Breidablikk was scheduled to start in the first half of 2024, with predrilling and completion of five wells. However, eight wells have already been drilled and the drilling of additional wells will continue on the field until the end of 2025.
Investments in the project are expected to be just over 21 billion Norwegian kroner ($1.91 billion) and the field holds almost 200 million barrels of recoverable oil.
"At peak, Breidablikk is expected to send up to 55,000-60,000 barrels of oil to the market daily, mainly to Europe," said Kjetil Hove, Equinor's executive vice president for exploration and production Norway.
Partners in the field are Equinor as operator with a 39% share, Var Energi with 34.4%, Petoro with 22.2% and ConocoPhillips with 4.4%.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
October 20, 2023 04:27 ET (08:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom